• Title of article

    Hematuria in Patients With Beta-Thalassemia Major

  • Author/Authors

    Fallahzadeh, Mohammad Hossein shiraz university of medical sciences - Shiraz Nephro-Urology Research Center, شيراز, ايران , Fallahzadeh, Mohammad Hossein shiraz university of medical sciences - Department of Pediatric Nephrology, شيراز, ايران , Fallahzadeh, Mohammad K shiraz university of medical sciences - Shiraz Nephro-urology Research Center, شيراز, ايران , Fallahzadeh, Mohammad K shiraz university of medical sciences - Department of Pediatric Nephrology, شيراز, ايران , Shahriari, Mehdi shiraz university of medical sciences - Department of Pediatric Hematology, شيراز, ايران , Rastegar, Shervin shiraz university of medical sciences - Shiraz Nephro-urology Research Center, شيراز, ايران , Rastegar, Shervin shiraz university of medical sciences - Department of Pediatric Nephrology, شيراز, ايران , Derakhshan, Ali shiraz university of medical sciences - Department of Pediatrics, شيراز, ايران , Derakhshan, Ali shiraz university of medical sciences - Shiraz Nephro-Urology Research Center, شيراز, ايران , Fallahzadeh, Mohammad Amin shiraz university of medical sciences - Shiraz Nephro-urology Research Center, شيراز, ايران , Fallahzadeh, Mohammad Amin shiraz university of medical sciences - Department of Pediatric Nephrology, شيراز, ايران

  • From page
    133
  • To page
    136
  • Abstract
    Introduction. Our information about renal involvement in betathalassemia major is limited. Recently, few studies have reported proteinuria, hypercalcuria, phosphaturia, and oversecretion of tubular damage markers; however, hematuria has not yet been meticulously studied in these patients. We investigated hematuria in patients with beta-thalassemia major. Materials and Methods. Urinalysis was performed in 500 patients with beta-thalassemia major under a regular blood transfusion program. In those with hematuria (at least 3 to 5 erythrocytes per high-power field) a second urinalysis was done at the nexttransfusion time. Results. The patients ranged in age from 6 months to 32 years. The male-female ratio was 1.05:1. Hematuria was detected in 55 (10.6%), including 9.8% of those younger than 20 years and 20.0% of those older than 20 years. Hematuria was persistent in 79.2% of the second urinalyses. Sixty-four percent of the patients with hematuria were females. A blood transfusion program had been started during the first year of life in 81% percent of the patients with hematuria. Sterile pyuria was detected in 4% and proteinuria in 16% of the patients with hematuria, while thesefigures in patients without hematuria were 2.1% (P = .56) and 1.4% (P = .002), respectively. Conclusions. We found that in patients with beta-thalassemia major, the risk of hematuria rises with age. Moreover, proteinuria seems to be more common in those with hematuria. Further studies areneeded to ascertain the importance of these findings.
  • Keywords
    beta , thalassemia , proteinuria , urinalysis , deferoxamine , iron overload
  • Journal title
    Iranian Journal of Kidney Diseases (IJKD)
  • Journal title
    Iranian Journal of Kidney Diseases (IJKD)
  • Record number

    2669733